The CBD gummies market is anticipated to be worth USD 743.5 million in 2023. Revenue from the sales of CBD gummies is forecasted to reach USD 7,524.5 million by 2033. Exhibiting a remarkable 26% CAGR between 2023 and 2033.
Along with its health benefits, clement CBD regulations for retail CBD based-products such as CBD oil, CBD gummies, CBD beverages, and others contribute to its growth. The prevalence of a high degree of awareness regarding the various benefits of CBD (Cannabidiol), ranging from improving cognitive function to treating skin problems, is aiding its consumption, substantially driving the market trends in recent years.
Several health benefits of CBD gummies include relief from inflammation and pain, identified as the major source of rising demand for CBD gummies in the medical sector. CBD gummies for anxiety have strong evidence of success in popular culture, which is anticipated to be the foremost factor for higher sales of CBD gummies in the local market.
| Attributes | Details |
|---|---|
| CBD Gummies Market Share (2022) | USD 715 million |
| CBD Gummies Market Size Value (2023) | USD 743.5 million |
| CBD Gummies Market Size Value (2033) | USD 7,524.5 million |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The demand for the CBD gummies segment increased by 4% between 2020 and 2022, giving the combined edible CBD market year-over-year growth of 29.0% in 2022, according to the FMI report.
It held more than 55% of the global market in pre-Covid 2019. CBD gummies consumption is increasing rapidly across European markets as manufacturers focus more on products with clean labels and THC content of less than 0.2%.
A few favorable changes in the overall regulations of hemp-based products promote the supply of CBD-based products in the United States market. High CBD-concentrated gummies are projected to register the fastest CAGR of 34.7% from 2021 to 2028 in the region due to increasing awareness about marijuana's benefits for sleep disorders. The conventional distribution channel accounted for 56.4% of sales in 2020. The demand for CBD gummies soared in the UK amid Covid lockdowns.
Many different types of medicines are on the market worldwide, including acetaminophen, aspirin, ibuprofen, and naproxen, each of which has quite dangerous adverse effects. On the contrary hand, by increasing endocannabinoid receptor activation, lowering inflammation, and working in conjunction with neurotransmitters, these products can aid in the reduction of chronic pain. Over the projection period, the demand for CBD gummies is expected to increase due to these health advantages.
CBD gummies have quickly become a popular trend and for good reason. They're fun, tasty, and easy to use medications. Plus, they provide all the benefits of CBD oil without any potential drawbacks. Such advantages without any potential damage probability are getting more sales of CBD gummies in the global market.
Principal Consultant
In their report, the WHO concluded that CBD is generally well tolerated with a good safety profile. CBD gummies have also improved hyperactivity and autism in specially-abled children.
However, marijuana is illegal on the federal (USA) level, and it is not legal to give THC to children. Still, CBD-based and hemp-based products below 0.3% THC are legal; hence, it is up to the parent to make a responsible decision regarding CBD gummies for kids.
As per the report, high CBD concentrated gummies accounted for the largest share of the global market by contributing nearly 28.2% of the total sales achieved that year.
While CBD isolates gummies account for 25.4% of the market in terms of product type due to increasing demand for gummies with no THC or cannabinoids. By concentration, the low-concentrated CBD gummies held 20.2% in 2020 and are expected to maintain their growth rate in the global CBD gummies industry during the projected years. First-time buyers of CBD gummies prefer low CBD content gummies ranging from 1 to 20 mg per gummy.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Conventional distribution channels are still the prominent segment channelizing about 56.4% of global sales. Customers favor offline retailers when looking to buy genuine goods. Any CBD product is available from local pharmacies with a special prescription. Furthermore, because head shops are widely distributed across most major cities, they benefit from a sizable established audience and a committed local clientele.
In recent years, the online distribution channel is gaining momentum with a higher growth rate with the proliferation of online platforms. Owing to the pandemic's widespread shutdown of all brick-and-mortar establishments, overall sales through offline channels substantially decreased.
North America is likely to remain the dominant market through the projected years. In the North America geographical region, the United States is the largest shareholder, with a total contribution of around 42%. The formulation of regulations about the legal or medical use of cannabinoids, particularly in California State, is responsible for higher sales of CBD gummies there.
Likewise, there has been a rapid rise in demand for CBD-based products in Europe. CBD regulations are getting softer. Authorities in E.U. Member States now regard CBD as a "novel product" for food, beverages, and food supplements. In the European CBD gummies industry, Germany is figured out to be the highest contributing market, with a share of around 38%.
As per the report, Asia Pacific is the remarkably growing in recent years. In this part of the world, China is the leading player with the
Japan loosened CBD regulations in 2016, but the change in regulation was unknown to many since bans on advertisements continued. It was only in 2018 that an amendment again resulted in the approval of an ad for Elixinol's CBD-based products.
Since then, the nation has recorded a multifold rise in the demand for CBD-based products, attracting investments from many international players in the CBD gummies industry. The positioning of Japan in the product life cycle (PLC) depicts it as a high-potential market.
The region has much slower growth compared to its counterparts, mainly due to a lack of awareness of CBD gummies' benefits and CBD regulations. Inclination towards Western ways of living has fuelled the demand for health-boosting products. Asia Pacific is relatively unexplored as a potential CBD market. Several hemp-based and CBD-based products have business potential in Thailand following the announcement of the new regulatory reforms.
The 2018 Agriculture Improvement Act, commonly called the 2018 farm bill act, permitted companies to grow and sell hemp-based products sourced from parts of the plant called cannabis Sativa L, including all derivatives and seeds. The market is benefitting from some favorable changes in regulations.
This act includes the removal of hemp from the Controlled Substances Act (CSA), which means that under federal law, cannabis plants and derivatives that constitute less than or equal to 0.3 % dry-weight THC are no longer controlled substances.
These developments positively affected the market, enabling manufacturers to expand their product portfolio, fuelling the demand for CBD gummies, and encouraging product launches in North America. For instance 2018, CV Sciences, Inc. announced the launch of Plus CBD Gummies at Natural Product Expo East 2018. Plus, CBD Gummies are available in two flavors- Citrus Punch and Cherry Mango.
The product's growing popularity among pet owners is a very recent and lucrative opportunity getting into focus of the new market players. The best CBD dog treats can help with pain management, anxiety, inflammation, arthritis, and seizure disorders. In the USA, there is a huge market for CBD-based dog foods. Brands like Honestpaws, Holistapet, and cbdMD already produce CBD gummies for dogs making it a growing segment in the global CBD gummies industry.
Several companies have recently launched their line of CBD gummies, including Green Roads and Lord Jones. These companies hope CBD gummies will be as popular as other CBD products, such as oils and tinctures.
In 2018, the Food and Drug Administration (FDA) concluded that CBD-based products can be legally marketed in human food, provided they comply with the requirements. Following this, the use of hemp extracts in food items such as CBD gummies has surged. This inevitably creates incremental prospects for sales uptick of CBD-based products.
Countries in Latin America have legalized cannabis for medical use, including Colombia, Chile, Mexico, Brazil, Peru, and Argentina. In Colombia, CBD-based products, including CBD gummies, can be legally sold through retail channels provided they contain <1% THC (Tetrahydrocannabinol) and are licensed by Colombia's food and drug regulatory agency. Prominent brands from this region include Bluebird Botanicals (Brazil), Green Roads (Chile), and Mary's Nutritionals (Brazil).
The leading firms in the global CBD gummies industry, which have a sizable core audience, well-known brands, extensive networks of distributors, and a constant expansion of their footprint across key areas, provide the most rivalry for the industry's participants.
Champs, Inc. and First Capital Venture Co., a PotNetwork Holdings division and Diamond CBD proprietor, negotiated an exclusive distribution contract in February 2021. This collaborative endeavor aims to increase Diamond CBD's market share by introducing products endorsed by athletes.
The global CBD gummies industry is to grow at 26% during the forecast period.
The global CBD gummies industry is predicted to be valued at USD 7,524.5 million by 2033.
The global CBD gummies market was valued at USD 743.5 million in 2023.
The high CBD concentrated gummies market contributed 28.2% of the global market in 2022.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type 5.1. High CBD Concentrated Gummies 5.2. CBD Isolate Gummies 5.3. Broad-spectrum CBD Gummies 5.4. Full-spectrum CBD Gummies 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Sale Channel 6.1. Conventional Distribution Channel 6.1.1. Supermarket/ Hypermarket 6.1.2. Head Shops 6.1.3. Smoke Shops 6.1.4. Local Health Stores 6.1.5. Others 6.2. Online Retailing 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Packaging 7.1. Pouches 7.2. Bottles 7.3. Jars 7.4. Tins 7.5. Others 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16. Key Countries Market Analysis 17. Market Structure Analysis 18. Competition Analysis 18.1. CV Sciences 18.2. Charlotte's Web 18.3. Verma Farms 18.4. PureKana 18.5. Dixie Brands Inc. 18.6. Premium Jane 18.7. Kushie Bites 18.8. Sunday Scaries 18.9. Hemp Bombs 18.10. Reliva CBD Wellness 18.11. CBD Oil Europe 18.12. Medterra 18.13. Balance CBD 18.14. CBDfx 18.15. CBD Pure 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Food and Beverage Insights
View Reports
CBD Gummies Market
